Blencowe Resources: Aspiring to become one of the largest graphite producers in the world. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCropper (J) Regulatory News (CRPR)

Share Price Information for Cropper (J) (CRPR)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 410.00
Bid: 390.00
Ask: 430.00
Change: -15.00 (-3.53%)
Spread: 40.00 (10.256%)
Open: 420.00
High: 420.00
Low: 410.00
Prev. Close: 425.00
CRPR Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Grant of Awards under Long Term Incentive Plan

20 Dec 2023 07:00

RNS Number : 3585X
Cropper(James) PLC
20 December 2023
 

James Cropper plc

("James Cropper", the "Company or the "Group")

 

Grant of Awards under Long Term Incentive Plan

 

James Cropper (AIM: CRPR), a global market leader in advanced materials and paper products, announces that the following awards of options ("Options") were made on 19 December 2023 ("Award Date") under the Company's Long-Term Incentive Plan ("LTIP"), to certain PDMRs over ordinary shares in the Company of 25p each ("Ordinary Shares"):

 

 

PDMR

Position

Number of Ordinary Shares*

1.

Steve Adams

Chief Executive Officer

27,110

2.

Andrew Goody

Chief Financial and Operations Officer

13,977

3.

Patrick Willink

Chief Innovation Officer

13,037**

4.

Richard Bracewell

Managing Director, Paper products

11,608

5.

Matt Ratcliffe

General Counsel and Company Secretary

6,384

6.

Rachel Armer

People and Culture Director

5,021

 

*Determined using a price of 646p per Ordinary Share, being the Company's 20-day average closing price for Ordinary Shares.

**Conditional cash award: to be satisfied in cash based upon the market value of vested shares at the date of exercise.

 

The Options were awarded for nil-cost subject to the rules of the LTIP and will be exercisable from the third anniversary of the Award Date to the tenth anniversary of the Award Date.

 

Vesting of the Options is subject to stretching performance targets determined by the Remuneration Committee relating to a three-year performance period covering the financial years 2023/24, 2024/25 and 2025/26. Performance targets have been set against the following measures:

 

Performance measure Weighting

Growth in adjusted Earnings Per Share ("EPS") 40%

Cumulative operating cash flow 30%

Reduction in carbon emissions intensity ratio 30%

 

Each performance measure is structured with a threshold target (resulting in 10% vesting) and a maximum target (resulting in 100% vesting). Vesting is adjusted on a straight-line basis between threshold and maximum targets. Awards will lapse to the extent that performance is below the threshold target for each performance measure.

 

The adjusted EPS performance targets are set from a base adjusted EPS of 25.1 pence and are as follows:

Threshold

Maximum

Target

Compound annual growth in adjusted EPS of 35%

Compound annual growth in adjusted EPS of 70%

Vesting

10%

100%

Enquiries

 

James Cropper plc

Matt Ratcliffe, General Counsel and Company Secretary

Tel: +44 (0) 1539 722 002

 

Shore Capital - (NOMAD and Broker)

Robert Finlay, Henry Willcocks, Lucy Bowden

Tel: +44 (0) 7601 6100

 

Buchanan Communications - Financial PR

Chris Lane, Charles Ryland, Jamie Hooper, Verity Parker

jamescropper@buchanancomms.co.uk

Tel: +44 (0) 207 466 5000

 

 

The following information is included in accordance with Article 19(3) of the Market Abuse Regulation (No. 596/2014):

1.

Details of person discharging managerial responsibilities/person closely associated

 

a)

Name

1. Steve Adams

2. Andrew Goody

3. Patrick Willink

4. Richard Bracewell

5. Matt Ratcliffe

6. Rachel Armer

 

2.

 

Reason for the notification

a)

Position/status

1. Chief Executive Officer

2. Chief Financial and Operations Officer

3. Chief Innovation Officer

4. Managing Director, Paper Products

5. General Counsel and Company Secretary

6. People and Culture Director

 

 

b)

Initial notification/amendment

Initial Notification

3.

Details of the issuer

 

a)

Name

James Cropper plc

 

b)

Legal Entity Identifier

213800XM78VTDYGBRM93

 

4.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted.

 

a)

Description of the

financial instrument

Ordinary Shares of 25 pence each

b)

Identification code of the Financial Instrument

GB0002346053

c)

Nature of the

transaction

Award of nil-cost options under the Company's Long Term Incentive Plan

d)

Currency

GBP

 

e)

Price(s) and volume(s)

 

Price(s)

Volume(s)

1. Nil-Cost

27,110

2. Nil-Cost

13,977

3. Nil-Cost

13,037

4. Nil-Cost

11,608

5. Nil-Cost

6,384

6. Nil-Cost

5,021

 

f)

Aggregated

information

- volume

- Price

- Total

 

 

 

N/A

g)

Date of the transaction

18 December 2023

 

h)

Place of the transaction

Outside trading venue 

 

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHFLFLRFTLALIV
Date   Source Headline
1st Aug 20187:00 amRNSDirector/PDMR Shareholding and Total Voting Rights
1st Aug 20187:00 amRNSDirector Appointment
31st Jul 20181:16 pmRNSDirector/PDMR Shareholding
30th Jul 20187:00 amRNSDirector/PDMR Shareholding
25th Jul 201811:00 amRNSAGM Statement and Trading Update
24th Jul 20187:00 amRNSDirector/PDMR Shareholding
20th Jul 20187:38 amRNSDirector/PDMR Shareholding
18th Jul 20187:00 amRNSDirector/PDMR Shareholding
4th Jul 201811:46 amRNSDirector/PDMR Shareholding
4th Jul 20187:00 amRNSDirector/PDMR Shareholding
29th Jun 20187:00 amRNSDirector/PDMR Shareholding
26th Jun 20187:00 amRNSFinal Results
22nd Mar 20182:24 pmRNSDirector/PDMR Shareholding
19th Mar 201812:57 pmRNSDirector/PDMR Shareholding
9th Mar 201810:06 amRNSDirector/PDMR Shareholding
24th Jan 20187:00 amRNSTrading update
18th Jan 20189:25 amRNSDirector/PDMR Shareholding
18th Jan 20187:00 amRNSDirector/PDMR Shareholding
15th Jan 201811:22 amRNSDirector/PDMR Shareholding
3rd Jan 201810:21 amRNSHolding(s) in Company
20th Dec 201710:35 amRNSDirector/PDMR Shareholding
20th Dec 20177:00 amRNSDirector/PDMR Shareholding
18th Dec 201710:34 amRNSDirector/PDMR Shareholding
15th Dec 201712:11 pmRNSDirector/PDMR Shareholding
30th Nov 20177:00 amRNSDirector/PDMR Shareholding
23rd Nov 20177:00 amRNSDirector/PDMR Shareholding
22nd Nov 20177:00 amRNSDirector/PDMR Shareholding
21st Nov 20177:00 amRNSDirector/PDMR Shareholding
14th Nov 201712:40 pmRNSReplacement - Half-year Report
14th Nov 20177:00 amRNSHalf-year Report
11th Oct 201710:56 amRNSTrading update
27th Sep 20173:28 pmRNSDirector/PDMR Shareholding
26th Sep 20177:00 amRNSDirector/PDMR Shareholding
25th Sep 20179:43 amRNSDirector/PDMR Shareholding
22nd Sep 201710:57 amRNSDirector/PDMR Shareholding
18th Sep 20174:05 pmRNSDirector/PDMR Shareholding
15th Sep 20172:43 pmRNSDirector/PDMR Shareholding
15th Sep 20179:44 amRNSDirector/PDMR Shareholding
14th Sep 20174:52 pmRNSDirector/PDMR Shareholding
7th Sep 20172:29 pmRNSDirector/PDMR Shareholding
7th Sep 201711:30 amRNSDirector/PDMR Shareholding
1st Sep 20171:27 pmRNSDirector/PDMR Shareholding
25th Aug 201710:50 amRNSDirector/PDMR Shareholding
23rd Aug 20177:00 amRNSDirector/PDMR Shareholding
22nd Aug 201710:23 amRNSDirector/PDMR Shareholding
21st Aug 201711:38 amRNSDirector/PDMR Shareholding
18th Aug 201710:14 amRNSDirector/PDMR Shareholding
18th Aug 201710:10 amRNSHolding(s) in Company
8th Aug 201710:49 amRNSLTIP Award and Directors Dealings
2nd Aug 20173:21 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.